Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 211

1.

Midlife cardiovascular risk factors, ApoE, and cognitive decline in elderly male twins.

Carmelli D, Swan GE, Reed T, Miller B, Wolf PA, Jarvik GP, Schellenberg GD.

Neurology. 1998 Jun;50(6):1580-5.

PMID:
9633697
2.

Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: the ARIC MRI Study.

Knopman DS, Mosley TH, Catellier DJ, Coker LH; Atherosclerosis Risk in Communities Study Brain MRI Study.

Alzheimers Dement. 2009 May;5(3):207-14. doi: 10.1016/j.jalz.2009.01.027. Epub 2009 Apr 11.

PMID:
19362884
3.

Memory complaints and APOE-epsilon4 accelerate cognitive decline in cognitively normal elderly.

Dik MG, Jonker C, Comijs HC, Bouter LM, Twisk JW, van Kamp GJ, Deeg DJ.

Neurology. 2001 Dec 26;57(12):2217-22.

PMID:
11756600
4.

The role of APOE-epsilon4 in longitudinal cognitive decline: MacArthur Studies of Successful Aging.

Bretsky P, Guralnik JM, Launer L, Albert M, Seeman TE; MacArthur Studies of Successful Aging.

Neurology. 2003 Apr 8;60(7):1077-81.

PMID:
12682309
5.

APOE-epsilon4 is associated with memory decline in cognitively impaired elderly.

Dik MG, Jonker C, Bouter LM, Geerlings MI, van Kamp GJ, Deeg DJ.

Neurology. 2000 Apr 11;54(7):1492-7.

PMID:
10751265
6.

Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment.

Caselli RJ, Reiman EM, Locke DE, Hutton ML, Hentz JG, Hoffman-Snyder C, Woodruff BK, Alexander GE, Osborne D.

Arch Neurol. 2007 Sep;64(9):1306-11.

PMID:
17846270
7.

Impact of APOE status on cognitive maintenance in healthy elderly persons.

Zehnder AE, Bläsi S, Berres M, Monsch AU, Stähelin HB, Spiegel R.

Int J Geriatr Psychiatry. 2009 Feb;24(2):132-41. doi: 10.1002/gps.2080.

PMID:
18615849
8.
9.

Plasma levels of apolipoprotein E and cognitive function in old age.

Mooijaart SP, van Vliet P, van Heemst D, Rensen PC, Berbée JF, Jolles J, de Craen AJ, Westendorp RG.

Ann N Y Acad Sci. 2007 Apr;1100:148-61.

PMID:
17460173
10.

Apolipoprotein E, cardiovascular disease and cognitive function in aging women.

Kang JH, Logroscino G, De Vivo I, Hunter D, Grodstein F.

Neurobiol Aging. 2005 Apr;26(4):475-84.

PMID:
15653176
11.
12.

Memory performance in healthy elderly without Alzheimer's disease: effects of time and apolipoprotein-E.

Mayeux R, Small SA, Tang M, Tycko B, Stern Y.

Neurobiol Aging. 2001 Jul-Aug;22(4):683-9.

PMID:
11445269
13.

Association between ApoE epsilon4 and cognitive impairment after stroke.

Wagle J, Farner L, Flekkøy K, Wyller TB, Sandvik L, Eiklid KL, Fure B, Stensrød B, Engedal K.

Dement Geriatr Cogn Disord. 2009;27(6):525-33. doi: 10.1159/000223230. Epub 2009 Jun 4.

PMID:
19494491
14.

APOE epsilon4 and cognitive decline in older stroke patients with early cognitive impairment.

Ballard CG, Morris CM, Rao H, O'Brien JT, Barber R, Stephens S, Rowan E, Gibson A, Kalaria RN, Kenny RA.

Neurology. 2004 Oct 26;63(8):1399-402.

PMID:
15505155
15.

The relationship of APOE genotype to cognitive functioning in older African-American and Caucasian community residents.

Fillenbaum GG, Landerman LR, Blazer DG, Saunders AM, Harris TB, Launer LJ.

J Am Geriatr Soc. 2001 Sep;49(9):1148-55.

PMID:
11559372
16.

APOE and cognitive decline in preclinical Alzheimer disease and non-demented aging.

Bunce D, Fratiglioni L, Small BJ, Winblad B, Bäckman L.

Neurology. 2004 Sep 14;63(5):816-21.

PMID:
15365129
17.

Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease.

Hoyt BD, Massman PJ, Schatschneider C, Cooke N, Doody RS.

Arch Neurol. 2005 Mar;62(3):454-9.

PMID:
15767511
18.

APOE-epsilon4, depressive symptoms, and cognitive decline in Chinese older adults: Singapore Longitudinal Aging Studies.

Niti M, Yap KB, Kua EH, Ng TP.

J Gerontol A Biol Sci Med Sci. 2009 Feb;64(2):306-11. doi: 10.1093/gerona/gln013. Epub 2009 Jan 30.

19.

Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.

Devanand DP, Pelton GH, Zamora D, Liu X, Tabert MH, Goodkind M, Scarmeas N, Braun I, Stern Y, Mayeux R.

Arch Neurol. 2005 Jun;62(6):975-80.

PMID:
15956169
20.

Risk factors for mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 2.

Lopez OL, Jagust WJ, Dulberg C, Becker JT, DeKosky ST, Fitzpatrick A, Breitner J, Lyketsos C, Jones B, Kawas C, Carlson M, Kuller LH.

Arch Neurol. 2003 Oct;60(10):1394-9.

PMID:
14568809

Supplemental Content

Support Center